home / stock / clgn / clgn news


CLGN News and Press, CollPlant Holdings Ltd. From 11/25/25

Stock Information

Company Name: CollPlant Holdings Ltd.
Stock Symbol: CLGN
Market: NASDAQ
Website: collplant.com

Menu

CLGN CLGN Quote CLGN Short CLGN News CLGN Articles CLGN Message Board
Get CLGN Alerts

News, Short Squeeze, Breakout and More Instantly...

CLGN - CLGN - Historical Price Movements Surrounding Earnings

2025-11-25 17:41:44 ET CollPlant Biotechnologies Ltd. (CLGN) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 9.12%. The average open to low on the day of earnings was -8.90%. The average...

CLGN - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS PR Newswire REHOVOT, Israel , Nov. 18, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and produc...

CLGN - CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada PR Newswire -- New North American logistics center will provide expanded distribution for CollPlant's rhCollagen and BioInks as well as enable logistical efficiencies -- REHOVOT, Israel ...

CLGN - CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology PR Newswire A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D Ȓ...

CLGN - First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk PR Newswire The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical research. According to a s...

CLGN - US Companies Moving the Markets, Morning edition
Tue, Sep 30, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Beneficient (BENF) rose 57.6% to $0.5766 on volume of 125,684,534 shares Sky Quarry Inc. (SKYQ) rose 29.9% to $0.5889 on volume of 69,108,723 shares Tilray Brands Inc. (TLRY) fell 9.5% to $1.675 on volume of 36,697,592 shares Cre8 Ent...

CLGN - CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler PR Newswire CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the up...

CLGN - CollPlant Expands the Distribution of its VergenixSTR Product in Europe

CollPlant Expands the Distribution of its VergenixSTR Product in Europe PR Newswire REHOVOT, Israel , Sept. 15, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or ' CollPlant ' , a regenerative and aesthetics medicine company developing inn...

CLGN - CollPlant to Present at the 2025 International Conference on Biofabrication

CollPlant to Present at the 2025 International Conference on Biofabrication PR Newswire REHOVOT, Israel , Sept. 2, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies ...

CLGN - CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference PR Newswire REHOVOT, Israel , Aug. 25, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing d...

Previous 10 Next 10